In 2021 Biovision was bought for 320 000 000 USD by Abcam.

Danaher bought Abcam for 5 700 000 000 USD in september 2023

Following products are now part of Danaher:

1. Biovision Antibodies
2. Biovision Elisas
3. Biovision Recombinant